University of Nebraska Medical Center

Grey Matters (Attendee Information)

This site is intended for registered participants of the Grey Matters: Brain and Spine Cancer Symposium.

Grey Matters: Brain and Spine Cancer Symposium

Welcome! Thank you for joining us.

This symposium is designed to update the target audience on the current multi-disciplinary approach to patients with newly diagnosed or recurrent gliomas. Presentations will be delivered by key thought leaders while allowing the opportunity for participants to be involved in the interactive question/answer sessions.

Symposium Objectives

At the conclusion of this activity, the participant should be better able to:

  1. Discuss cutting-edge brain and spine cancer research initiatives and resources originating from trials at Nebraska Medicine.
  2. Summarize the collective responsibility of the multidisciplinary team approach in managing patients with newly diagnosed or recurrent gliomas for optimized patient outcomes while emphasizing shared accountability.
  3. Explain the importance of obtaining molecular testing in brain tumor patients for more personalized treatment strategies.
  4. Explain how gliomas can impact patients’ cognitive and physical function.

General Information

Faculty and Planning Committee Disclosures

Read the UNMC CCE Disclosure Declaration Policy 


The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.


The following faculty members have disclosed relevant financial relationships:

  • Michele R. Aizenberg, MD, FAANS, FACS*
    Research: Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc.
    Research Funding: National Institute of General Medical Sciences
  • Nicole A. Shonka, MD*
    Consultant: GT Medical Technologies, Inc.
  • Chi (Kevin) Zhang, MD, PhD
    Co-Founder: Zcure LLC
    Research Grant: AstraZeneca; BioMimetix

The following faculty members have nothing to disclose:

  • Sahara J. Cathcart, MD
  • Olga Taraschenko, MD, PhD


The following planning committee members have nothing to disclose:

  • Missy Edwards
  • Tori Greenlee
  • Julie Huglin
  • Brenda Ram, CMP, CHCP

 *Faculty and planning committee member 

Speaker Handouts

The following materials (in PDF) are available for download until May 9, 2024. No part of these materials may be reproduced without prior written permission.

Requirements for Successful Completion

In order to receive continuing education credits, you must:

  1. Check in and attend the live activity.
  2. Complete the online evaluation via the UNMC MyCCE portal.
    • On your dashboard, click Evaluate an Activity.
    • Enter Activity Code 59081.

You have until May 9, 2024, to claim credit for this activity. You will need to complete the evaluation and attest to the time you spent participating in the activity. Your certificate will be saved in your UNMC MyCCE account under Certificates & Transcripts.

Need help managing your MyCCE account? Find answers to commonly asked questions about signing in to the portal, completing the online evaluation, retrieving your certificate, and more. Go to Manage MyCCE Account

Symposium Directors

Michele R. Aizenberg, MD, FAANS, FACS

Professor, Department of Neurosurgery, UNMC
Director, Brain and Spine Cancer Center, Nebraska Medicine

Michele R. Aizenberg, MD, FAANS, FACS
Nicole A. Shonka, MD

Associate Professor, Division of Oncology and Hematology, Department of Internal Medicine, UNMC
Medical Director, Clinic and Infusion Center, Fred & Pamela Buffett Cancer Center

Nicole A. Shonka, MD


This symposium is co-sponsored by the UNMC Departments of Neurosurgery and Internal Medicine (Division of Oncology and Hematology), and Nebraska Medicine, through the resources of the UNMC Center for Continuing Education.



Missy Edwards

Educational Projects Coordinator
UNMC Center for Continuing Education


Missy Edwards